Chronic injury to the microcirculation in EMB

Similar documents
Interstitial Inflammation

Review of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology

Renal Pathology- Transplantation. Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic

Antibody-Mediated Rejection in the Lung Allograft. Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305

The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference

No evidence of C4d association with AMR However, C3d and AMR correlated well

Statement of Disclosure

Antibody Mediated Rejection (AMR) in LUNG TRANSPLANT Recipients

Antibody Mediated Rejection (AMR) in Heart Transplantation Session

Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA

AMR in Liver Transplantation: Incidence

Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection

Prof. Sandrine Florquin Department of Pathology Academic Medical Center University of Amsterdam Amsterdam, The Netherlands. Slide 1.

The multidisciplinary approach to AMR in lung transplantation: Reaching a consensus. Deborah Jo Levine Professor of Medicine University of Texas

Med Path Rads Conference Gurpreet Sodhi M.D.

RENAL EVENING SPECIALTY CONFERENCE

The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials

Management of Rejection

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017

Banff-SCT 2017 Towards Uniformity of Terminology for the Pathology of CAV. Gerald J. Berry, MD Dept. of Pathology Stanford University Stanford, CA

Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification

HLA and Non-HLA Antibodies in Transplantation and their Management

ABSTRACT AJCP /ORIGINAL ARTICLE. Downloaded from by guest on 07 January 2019

3/6/2017. Prevention of Complement Activation and Antibody Development: Results from the Duet Trial

Watermark. Interaction between Neuropathy and PAD

Supplementary appendix

Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III

Marta Farrero Torres₁, Marcelo Pando₂, Dolly Tyan₂, Hannah Valantine₃, Spenser Smith₃, Kiran Khush₃

Biopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Meeting Report. Introduction

Interpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA

Acute renal failure (ARF) in the transplanted kidney represents a

Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection

Case Presentation Turki Al-Hussain, MD

The Banff Conferences on renal allograft pathology the latest 2013 report

Basic Science in Transplantation. Greg Hirsch Atlantic Transplant Centre Dalhousie/CDHA

HLA Part II: My Patient Has DSA, Now What?

In the treatment of partial and full-thickness chronic wounds TRANSFORM YOUR APPROACH TO HEALING: SIGNAL THE BODY, NOT THE WOUND DERMA

Correspondence should be addressed to Tor Skibsted Clemmensen;

Research Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the

Posttransplant Human Leukocyte Antigen Antibodies in Stable Kidney Transplant Recipients

Treatment of Chronic Antibody Mediated Rejection

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Heart Transplant: State of the Art. Dr Nick Banner

2015 SCVP Young Investigator Award Presentations

Corporate Medical Policy

Solid Organ Transplant

Heart Transplantation is Dead

Repositioning of the Mineralocorticoid Receptor Antagonists in renal diseases: pathophysiological basis and therapeutic issues

Is Obliterative Bronchiolitis in Lung Transplantation Associated With Microvascular Damage to Small Airways?

Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Diploma Thesis. Lymphangiogenesis in Bronchiolitis Obliterans Syndrome. Denise Traxler-Weidenauer. Advisor: Priv.-Doz. Dr. Konrad HOETZENECKER, PhD

Update on Transplant Glomerulopathy

ACCME/Disclosure. Case #1. Case History. Dr. Bracamonte has nothing to disclose

Learning Objectives After completion of this Class, participants will have improved competence and professional performance in their ability to:

Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

The transcriptome of the renal transplant biopsy: the lessons. Philip F Halloran

MOLECULAR PREDICTORS OF OUTCOME Ondrej Viklicky, Prague, Czech Republic. Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

Pulmonary AMR Therapeutic Options & Strategies: The Old and the New. Ramsey Hachem, MD March 28, 2017

COMPETENCY CLASSES and MASTER CLASSES

DR as a Biomarker for Systemic Vascular Complications

Pros and cons for C4d as a biomarker

Vascular Remodelling in Pancreas Transplantation

DE-MYSTIFYING THE BLACK BOX OF TRANSPLANT IMMUNOLOGY

Subject: Laboratory Tests for Heart and Kidney Transplant Rejection

Recruitment of pre-existing vessels. versus. Angiogenesis

Supplementary Appendix

Form 4: Coronary Evaluation

Recognition and Treatment of Chronic Allograft Dysfunction

Antibody Mediated Rejection in Heart Transplantation

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Καρδιακή Ανεπάρκεια Ο ρόλος της απεικόνισης Ο Μεταμοσχευμένος Ασθενής. Αγγελική Γκουζιούτα Καρδιολόγος ΩΚΚ

A clear path forward COMING SOON THE LATEST INNOVATION IN KIDNEY TRANSPLANT SURVEILLANCE CAN DRIVE BETTER OUTCOMES FOR YOUR PATIENTS

Since the first Banff meeting in 1991, the diagnosis and

Histopathological evaluation of renal allograft biopsies in Nepal: interpretation and significance

Effect of Acute Allograft Rejection on Exercise Hemodynamics in Patients Who

Update on Transplant Glomerulopathy

Journal of the American College of Cardiology Vol. 39, No. 6, by the American College of Cardiology Foundation ISSN /02/$22.

Caffeine Modulates Hyperoxia - Induced Angiogenesis in Newborn Mice

Form 4: Coronary Evaluation

2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474)

Tissue repair. (3&4 of 4)

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine

The Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study

Form 4: Coronary Evaluation

Index. Note: Page numbers of article titles are in boldface type.

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy 2010

Populations Interventions Comparators Outcomes Individuals: With heart transplant

The use of pathology surrogate markers in Fabry Disease. Beth L. Thurberg MD PhD Vice President of Pathology Genzyme

Interesting case seminar: Native kidneys Case Report:

Desmin expression in cardiomyocytes - a good predictor of development of chronic heart failure.

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

Long-term efficacy and safety of conversion to tacrolimus in heart. transplant recipients with ongoing or recurrent acute cellular.

Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies

Transcription:

Chronic injury to the microcirculation in EMB Dylan V Miller MD M Patricia Revelo MD

Disclosures Miller: None Revelo: None

Goals & Objectives Characterize the tissue-level pathologic changes occurring in the microvasculature of failing cardiac allografts. Describe possible pathogenetic mechanisms accounting for microcirculation pathology in failing cardiac allografts. Review causal links between antibody mediated rejection (ABMR) and microcirculation pathology in failing cardiac allografts. Recognize tissue level histopathologic alterations in the myocardial microvasculature of failing cardiac allografts. Discuss possible mechanisms whereby microcirculation injury may lead to cardiac allograft failure and the reported histopathologic changes in this setting. Assess routine monitoring of microcirculation injury features in cardiac allograft biopsies to monitor long term effectiveness of antirejection therapy.

Ischemia/Wound Healing Paradigm Am J Pathol. 2010 Apr;176(4):2009-18 Microvasc Res. 2002 Jan;63(1):96-114. McDonald DM Angiogenesis and Remodeling of Airway Vasculature in Chronic Inflammation. Am J Respir Crit Care Med. 2001 Nov 15;164(S2):39-45. Dedkov EI, et al. Resistance vessel remodeling and reparative angiogenesis in the microcirculatory bed of long-term denervated skeletal muscles. Microvasc Res. 2002 Jan;63(1):96-114. Am J Pathol. 2001 Jun; 158(6): 2043 2055. Fuxe et al. Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation. Am J Pathol. 2010 Apr;176(4):2009-18 Labarrere CA, et al. Cardiac allograft vasculopathy: Microvascular arteriolar capillaries ('capioles") and survival. Front Biosci (Elite Ed). 2017 Jan 1;9:110-128.

Microvessel Density at

(ISHLT 2017)

CAV Case-Control Cohort Adult Heart Transplant Patients Mean age 51 68 Men, 32 women Cases: 41 patients with CAV Controls: 59 patients without CAV or any treated AMR matched for age / gender / era (1:2 ratio) 3 time points: 3 Months post transplant @ time of CAV diagnosis by angiography (mean 3.6 years) @ time of most recent biopsy (mean 7 years)

Microvessel Density Analysis Endomyocardial biopsies stained for CD34 Whole slide images captured Leica Biosystems Aperio Microvessel Analysis Algorithm Microvessel density (# vessels/unit area) Vascular perimeter (um) Vascular area (um 2 ) Vessel wall thickness (um) Hypothesis: CAV patients MVD, perimeter, area, thickness

*p= NS n= 8 n= 8 n= 8 n= 19 n= 18 n= 19 Cases Controls p= 0.001 p= 0.01 n= 36 n= 37 n= 39 n= 32 n= 26 n= 27 Cases Controls

Cases Controls n= 8 n= 8 n= 8 n= 19 n= 18 n= 19 Cases Controls n= 36 n= 37 n= 39 n= 32 n= 26 n= 27

Cases Controls n= 8 n= 8 n= 8 n= 19 n= 18 n= 19 Cases Controls n= 32 n= 26 n= 27 n= 36 n= 37 n= 39

n= 8 n= 8 n= 8 n= 19 n= 18 n= 19 Cases Controls n= 32 n= 26 n= 27 n= 36 n= 37 n= 39 Cases Controls

Ultrastructural Alterations in Explanted Failed Cardiac Allografts: Insights into "Chronic Rejection" Monica P. Revelo, MD U.T.A.H Cardiac Transplant Program Salt Lake City, UT

Background The long term effects of multiple repetitive antibodymediated rejection episodes on the cardiac allograft (i.e. chronic rejection ) are subject of much speculation, but sparse pathologic characterization Ultrastructural changes, including endothelial swelling and capillary basement membrane multilayering, have been described in this setting, but systematic studies of the prevalence, severity, and morphologic spectrum of these changes are lacking In contrast, in kidney literature it is well stablished that transplant glomerulopathy and peritubular capillary multilayering are hallmarks of chronic AMR Hammond, E, Ultrastructural Path 1994;18:213 Sis, B et al, Am J Transplantation 2007; 7:1743

Background Type of rejection Endothelial swelling Basement membrane multilayering Fibrosis AMR (2) 2 1 1 ACR (1) 0 0 1 Mixed (3) 3 2 2 None (4) 2 0 2 Revelo MP, et al 2016

Background

Aim Systematic study of perimyocyte capillaries using electron microscopy in failed explants due to cardiac allograft vasculopathy Correlate findings with prior episodes of cellular and/or antibody-mediated rejection Correlate findings with time post-transplant

Methods We identified 16 heart transplant recipients with advanced CAV requiring re-transplantation Ultrastructural examination was performed with special attention paid to endothelial swelling and capillary basement membrane multilayering 25 capillaries were examined in each case Correlations were made between these changes and the post-transplant interval, as well number of rejection episodes during that time, using Student s t- test for paired samples

Results Age at re-transplant 34 ( range 24-67) Sex 10 male (66.6%) Time post transplant 7.7 years (range 4-16) Primary heart disease: Ischemic Non-ischemic Congenital 7 6 3

Results The mean number of prior biopsies per patient showing acute cellular rejection was 12 (range: 0 to 26) The mean number of prior biopsies showing antibody-mediated rejection was 7 (range: 0 to 25) 4 cases showed definite structural capillary changes (basement membrane multilayering and endothelial swelling) 6 cases showed only endothelial swelling

Results cont..

Results cont..

Results The likelihood of showing multilayering correlated with time post-transplant (p<0.01), the number of cellular rejection biopsies per post-transplant year (p<0.01), as well as the number of antibody-mediated rejection biopsies per post-transplant year (p=0.05)

Conclusions Specific ultrastructural changes in explanted failed allografts were seen only in a small number of the hearts examined Although they were more likely after a longer engraftment interval and with greater numbers of episodes of either cellular or antibody mediated rejection Since the anticipated tissue level changes were not more universally seen in this series, additional mechanisms of late graft failure deserve further exploration

Gràcies!